Patent ID: 6372733
Filing Date: 2002-04-16
Classification: A61P,C07D

Abstract:
A compound selected from the group consisting of:(a) hexahydro-5-imino-3-propyl-1,4-thiazepine hydrochloride, (b) hexahydro-5-imino-6-propyl-1,4-thiazepine hydrochloride, (c) hexahydro-5-imino-7-methyl-1,4-thiazepine hydrochloride, (d) hexahydro-5-imino-2-methyl-1,4-thiazepine hydrochloride, (e) hexahydro-5-imino-6-(3-methyl-2-n-butenyl)-1,4-thiazepine hydrochloride, (f) hexahydro-5-imino-3-(3-methyl-2-n-butenyl)-1,4-thiazepine hydrochloride, (g) hexahydro-5-imino-6-(2-methyl-propyl)-1,4-thiazepine hydrochloride, (h) hexahydro-5-imino-3-(2-methyl-propyl)-1,4-thiazepine hydrochloride, (i) hexahydro-5-imino-6-methyl-1,4-thiazepine hydrochloride, (j) hexahydro-5-imino-3-methyl-1,4-thiazepine hydrochloride, (k) hexahydro-5-imino-3-ethyl-1,4-thiazepine hydrochloride, (l) hexahydro-5-imino-3-butyl-1,4-thiazepine hydrochloride, (m) hexahydro-5-imino-3-(2-methyl-3-propenyl)-1,4-thiazepine hydrochloride, (n) (Â±)-trans-decahydro-4-imino-benzo[b]-1,4-thiazepine acetic acid salt, (o) hexahydro-5-imino-3(S)-propyl-1,4-thiazepine acetic acid salt, (p) hexahydro-5-imino-3(R)-propyl-1,4-thiazepine acetic acid salt, and pharmaceutically acceptable salts thereof.